Jelinek MJ - Search Results

1

Jelinek MJ, Joshi N. Jelinek MJ, et al. Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):8-9. doi: 10.1016/j.ijrobp.2023.11.045. Int J Radiat Oncol Biol Phys. 2024. PMID: 38631749 No abstract available.

2

Current State and Future Directions of EGFR-Directed Therapy in Head and Neck Cancer.

Tathineni P, Joshi N, Jelinek MJ. Tathineni P, et al. Among authors: jelinek mj. Curr Treat Options Oncol. 2023 Jun;24(6):680-692. doi: 10.1007/s11864-023-01080-5. Epub 2023 Apr 17. Curr Treat Options Oncol. 2023. PMID: 37067660 Review.

3

Impact of Routine Surveillance Imaging on Recurrence in Sinonasal Malignancies.

King K, Rauch R, Roy S, Menyok O, Tatebe K, Tajudeen B, Papagiannopoulos P, Batra PS, Bhayani M, Al-Khudari S, Stenson K, Jelinek MJ, Fidler MJ, Joshi N. King K, et al. Among authors: jelinek mj. Anticancer Res. 2022 Nov;42(11):5449-5455. doi: 10.21873/anticanres.16049. Anticancer Res. 2022. PMID: 36288895

4

A Novel Immobilization Method for the Treatment of Head and Neck Cancer Using 3D Printing.

Szewczyk C, Liao Y, Al-Khudari S, Jelinek MJ, Tatebe K. Szewczyk C, et al. Among authors: jelinek mj. Pract Radiat Oncol. 2024 Jan-Feb;14(1):20-23. doi: 10.1016/j.prro.2023.08.015. Epub 2023 Sep 24. Pract Radiat Oncol. 2024. PMID: 37751796

5

Air pollution is associated with increased incidence-rate of head and neck cancers: A nationally representative ecological study.

Ochoa Scussiatto H, Stenson KM, Al-Khudari S, Jelinek MJ, Pinto JM, Bhayani MK. Ochoa Scussiatto H, et al. Among authors: jelinek mj. Oral Oncol. 2024 Mar;150:106691. doi: 10.1016/j.oraloncology.2024.106691. Epub 2024 Jan 23. Oral Oncol. 2024. PMID: 38266316

6

Four-Phase, Definitive Chemoradiation for a Real-World (Poor Risk and/or Elderly) Patient Population With Locally Advanced Non-small Cell Lung Cancer.

Zhou YM, Shin J, Jelinek M, Fidler MJ, Batus M, Bonomi PD, Marwaha G. Zhou YM, et al. Among authors: jelinek m. Cureus. 2022 Sep 21;14(9):e29423. doi: 10.7759/cureus.29423. eCollection 2022 Sep. Cureus. 2022. PMID: 36299962 Free PMC article.

7

Presence of CrkI-containing microvesicles in squamous cell carcinomas could have ramifications on tumor biology and cancer therapeutics.

Mohamed MF, Al-Khudari S, Cassini-Vieira P, Erra A, Bagabas R, Houser T, Stenson K, Bhayani M, Jelinek MJ, Bishehsari F, Kuzel TM, Shafikhani SH. Mohamed MF, et al. Among authors: jelinek mj. Sci Rep. 2022 Mar 21;12(1):4803. doi: 10.1038/s41598-022-08905-7. Sci Rep. 2022. PMID: 35314778 Free PMC article.

8

A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study.

Bestvina CM, Pointer KB, Karrison T, Al-Hallaq H, Hoffman PC, Jelinek MJ, Juloori A, Melotek JM, Murgu S, Partouche J, Vokes EE, Weichselbaum RR, Pitroda SP, Patel JD, Chmura SJ. Bestvina CM, et al. Among authors: jelinek mj. J Thorac Oncol. 2022 Jan;17(1):130-140. doi: 10.1016/j.jtho.2021.08.019. Epub 2021 Sep 6. J Thorac Oncol. 2022. PMID: 34500113 Free article. Clinical Trial.

9

A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101.

Jelinek MJ, Foster NR, Zoroufy AJ, Schwartz GK, Munster PN, Seiwert TY, de Souza JA, Vokes EE. Jelinek MJ, et al. Oral Oncol. 2021 Mar;114:105171. doi: 10.1016/j.oraloncology.2020.105171. Epub 2021 Jan 26. Oral Oncol. 2021. PMID: 33513474 Free PMC article. Clinical Trial.

10

Adjuvant Osimertinib: A New Standard of Care.

Jelinek MJ, Aggarwal C. Jelinek MJ, et al. Oncologist. 2021 Apr;26(4):263-265. doi: 10.1002/onco.13634. Epub 2020 Dec 24. Oncologist. 2021. PMID: 33301209 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page